Organic compounds -- part of the class 532-570 series – Organic compounds – Polycyclo ring system containing anthracene configured ring...
Patent
1997-09-19
1999-07-13
Killos, Paul J.
Organic compounds -- part of the class 532-570 series
Organic compounds
Polycyclo ring system containing anthracene configured ring...
514570, C07C 5016
Patent
active
059228911
ABSTRACT:
2-substituted 1,8-dihydroxy-9(10h)-anthracenones, therapeutic compositions containing at least one novel 2-substituted 1,8-dihydroxy-9(10h)-anthracenone compound and methods of treating inflammatory conditions are provided.
REFERENCES:
B. Bonnekoh, et al., Arch. Pharm. (Weinheim) 324, 899-906 (1991).
Mueller, at al., Arch. Pharm. (Weinheim, Ger.), 320: 59-66 (1987).
Tranzer, et al., Arch. Pharm. (Weinheim, Ger.), 321: 447-449 (1988).
Mueller, et al., J. Med. Chem., 37: 1660-1669 (1994).
Finnen, M.J., Lancet II, 1129-1130 (1984).
Mueller, et al., Biochem. Pharmacol., 46: 1695-1704 (1993).
Corey et al, J. Am. Chem. Soc., 106: 1503-1504 (1984).
Takahashi, I et al, ChemPharm. Bull (1982) 30(12) 4539-44.
CA 116:50897 (1991).
Muller Klaus
Prinz Helge
Wiegrebe Wolfgang
Killos Paul J.
Teva Pharmaceutical Industries Ltd.
LandOfFree
2-substituted 1,8-dihydroxy-9(10H)-anthracenone pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted 1,8-dihydroxy-9(10H)-anthracenone pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted 1,8-dihydroxy-9(10H)-anthracenone pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2276795